Avalo Therapeutics, Inc. (AVTX) Insider Trading

Over the last 3 months, AVTX insiders made 0 open-market buys and 9 sales, a net sale of -$1.7M (SEC Form 4). Over the last 6 months, 33 institutions increased and 20 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
9
Net (3m)
-$1.7M
Insider trades by month Buys Sells
Mar
Apr
May
Jun
Jul
Aug
Context3-month price +22.6%Institutions reducing (13F)
DateInsiderTypeSharesPrice
Aug 19, 2026Sullivan Christopher Ryanofficer: Chief Financial OfficerOption2,876$9.88
Aug 19, 2026Doyle Mittieofficer: Chief Medical OfficerOption1,000$12.65
Aug 19, 2026Sullivan Christopher Ryanofficer: Chief Financial OfficerSell31,031$20.05
Aug 19, 2026Doyle Mittieofficer: Chief Medical OfficerSell1,000$20.00
Aug 19, 2026Sullivan Christopher Ryanofficer: Chief Financial OfficerOption31,031$9.88
Aug 19, 2026Sullivan Christopher Ryanofficer: Chief Financial OfficerSell37,945$19.85
Aug 19, 2026Sullivan Christopher Ryanofficer: Chief Financial OfficerSell3,749$19.94
Aug 19, 2026Sullivan Christopher Ryanofficer: Chief Financial OfficerOption37,945$9.88
Aug 12, 2026Doyle Mittieofficer: Chief Medical OfficerSell679$20.00
Aug 12, 2026Riley Jenniferofficer: Chief Strategy OfficerSell2,655$19.59
Aug 12, 2026Doyle Mittieofficer: Chief Medical OfficerOption679$8.04
Jul 29, 2026Doyle Mittieofficer: Chief Medical OfficerSell1,000$20.00
Jul 29, 2026Doyle Mittieofficer: Chief Medical OfficerOption1,000$12.65
Jul 2, 2026Doyle Mittieofficer: Chief Medical OfficerOption1,779$8.04
Jul 2, 2026Doyle Mittieofficer: Chief Medical OfficerSell4,654$20.00
Jul 2, 2026Lind Kevin RobertdirectorGrant1,105$18.48
Jul 2, 2026Doyle Mittieofficer: Chief Medical OfficerOption2,875$12.65
Jul 2, 2026Jain RitadirectorGrant1,080$18.48
Jul 2, 2026Philip Ron MdirectorGrant69$18.48
Jun 25, 2026Doyle Mittieofficer: Chief Medical OfficerSell1,450$18.00
Jun 25, 2026Philip Ron MdirectorGrant40,200$17.83
Jun 25, 2026Doyle Mittieofficer: Chief Medical OfficerOption1,450$8.04
Jun 12, 2026Riley Jenniferofficer: Chief Strategy OfficerTax588$13.10
Jun 12, 2026VARKI PAULofficer: Chief Legal OfficerTax1,081$13.10
Jun 12, 2026Doyle Mittieofficer: Chief Medical OfficerTax1,084$13.10
Jun 12, 2026Sullivan Christopher Ryanofficer: Chief Financial OfficerTax138$13.10
Jun 4, 2026KANTOFF AARONdirectorGrant20,100$13.96
Jun 4, 2026Heffernan Michael ThomasdirectorGrant29,500$13.96
Jun 4, 2026Truex SamanthadirectorGrant20,100$13.96
Jun 4, 2026Jain RitadirectorGrant20,100$13.96

Source: AVTX SEC Form 4 filings, latest Aug 19, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their AVTX positions over the last 6 months (SEC Form 13F).

Increased
33
New positions
35
Reduced
20
Sold out
101
Largest moves
InstitutionActionSharesFiled
FMR LLCIncreased2.9MMay 15, 2026
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.New Position2.2MMay 15, 2026
CALIGAN PARTNERS LPIncreased1.6MMay 15, 2026
BVF INC/ILIncreased1.6MMay 15, 2026
AVORO CAPITAL ADVISORS LLCNew Position1.4MMay 15, 2026
AFFINITY ASSET ADVISORS, LLCIncreased1.3MMay 14, 2026
LOGOS GLOBAL MANAGEMENT LPNew Position1.3MMay 15, 2026
NANTAHALA CAPITAL MANAGEMENT, LLCUnchanged1.2MMay 15, 2026
UBS GROUP AGIncreased1.1MMay 5, 2026
CAPTION MANAGEMENT, LLCIncreased1.1MMay 15, 2026
POINT72 ASSET MANAGEMENT, L.P.Increased916KMay 15, 2026
FARALLON CAPITAL MANAGEMENT LLCNew Position916KMay 15, 2026
RTW INVESTMENTS, LPNew Position857KMay 15, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.Increased854KMay 15, 2026
MILLENNIUM MANAGEMENT LLCIncreased835KMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.